Boulet Louis-Philippe, Hanania Nicola A
Québec Heart and Lung Institute, Université Laval, Québec, Canada.
Section of Pulmonary, Critical Care Medicine, Baylor College of Medicine, 1504 Taub Loop, Houston, TX 77030, USA.
Immunol Allergy Clin North Am. 2022 Aug;42(3):499-505. doi: 10.1016/j.iac.2022.05.001.
Asthma and chronic obstructive pulmonary disease (COPD) are common diseases that often overlap. The term asthma-COPD overlap (ACO) has been used to define this entity but there remain several speculations on its exact definition, impact, pathophysiology, and clinical features. Patients with ACO have greater morbidity than those with asthma or COPD alone, but the information on the best therapeutic approach to this group of patients is still limited. Current treatment recommendations rely on expert opinions, roundtable discussions, and strategy documents. It is prudent to examine existing knowledge about ACO and determine the path for future research.
哮喘和慢性阻塞性肺疾病(COPD)是常见疾病,且常相互重叠。“哮喘-慢性阻塞性肺疾病重叠综合征”(ACO)这一术语已被用于定义这一实体,但关于其确切定义、影响、病理生理学和临床特征仍存在多种推测。ACO患者的发病率高于单纯哮喘或COPD患者,但针对这组患者最佳治疗方法的信息仍然有限。目前的治疗建议依赖于专家意见、圆桌讨论和策略文件。审视关于ACO的现有知识并确定未来研究方向是审慎之举。